Work

315 Efficacy and Safety of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis: Results From TRuE-AD4, a Phase 3b, Randomized, Double-Blind, Vehicle-Controlled Study

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2025.09.317

Authors: José Manuel Carrascosa, Vimal H. Prajapati, H. Chih-ho Hong, Viktoria Eleftheriadou, Athanasios Tsianakas, Alexander Navarini, Ketty Peris, Eingun James Song, Raj Chovatiya, Sébastien Barbarot, Konstantin Popovic, Haq Nawaz, Qian Li, Andreas Wollenberg

Institutions: Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol, University of Calgary, Probity Medical Research, University of British Columbia, Walsall Healthcare NHS Trust, The Royal Wolverhampton NHS Trust, University of Birmingham, Fachklinik Hornheide, University Hospital of Basel, Rosalind Franklin University of Medicine and Science, Centre Hospitalier Universitaire de Nantes, Nantes Université, Incyte (United States), University Hospital Augsburg, Ludwig-Maximilians-Universität München, University of Lübeck

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4416073272

FWCI: 1.936

Cites:

Cited by: 2

Related to: 10